Status:
RECRUITING
The Application of a Novel Urinalysis System (UF-5000) for Reducing Unnecessary Antibiotic Use in Clinical Suspected UTI Patients
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Sysmex Asia Pacific
Conditions:
Urinary Tract Infections
Urinary Tract Infection Lower Acute
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Urinary tract infection (UTI) is one of the most common diseases in population while antibiotic resistant in UTI has become a critical problem in Hong Kong, that a large proportion of the bacteria in ...
Eligibility Criteria
Inclusion
- Adult patients who are suspected to have LUTs in outpatient clinic.
- Willing to consent to participate the trial.
- Be able to understand the nature of the study.
Exclusion
- Any suspected or known sexual transmitted diseases. (Such as gonorrhea, etc.)
- Use of any systematic antibiotics or antiviral treatment within two weeks
- With evidence of systematic infection including high fever, significantly increase of blood white blood cell count, etc.
- Known or suspected allergic history/adverse drug reactions to any antibiotics
- With previous history of multidrug resistant (MDR) bacterial infection.
- Any medical history that indicates the need of immediate antibiotics treatment, such as chronic conditions and/or taking immunosuppressants.
Key Trial Info
Start Date :
November 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06918769
Start Date
November 6 2023
End Date
February 28 2026
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong, Hong Kong